Thu, May 11, 2023
Revenue from operations rose to Rs 491 crore for the fourth quarter as compared with Rs 485 crore in the year-ago period, Dr Lal PathLabs said in a regulatory filing.
More >
Tue, Dec 13, 2022
Dr Lal PathLabs shares dropped sharply in Dec 13's trade amid reports that the Delhi government is set to provide 450 types of medical tests free of cost from Jan 1.
Wed, Nov 09, 2022
Indian service provider of diagnostics Dr Lal Pathlabs’ share fell more than 8% as company’s Profit After Tax (PAT) declined by 25% at Rs 72 crore as compared to Rs 96 crore in the corresponding quarter of the previous year
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.